BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27739048)

  • 1. The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.
    Curtis LT; Frieboes HB
    Adv Exp Med Biol; 2016; 936():165-190. PubMed ID: 27739048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment-Enabled Nanotherapy.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity.
    Curtis LT; England CG; Wu M; Lowengrub J; Frieboes HB
    Nanomedicine (Lond); 2016 Feb; 11(3):197-216. PubMed ID: 26829163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Drug-Loaded Gold Nanoparticle Cytotoxicity as a Function of Tumor Vasculature-Induced Tissue Heterogeneity.
    Miller HA; Frieboes HB
    Ann Biomed Eng; 2019 Jan; 47(1):257-271. PubMed ID: 30298374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving nanotherapy delivery and action through image-guided systems pharmacology.
    Ng TSC; Garlin MA; Weissleder R; Miller MA
    Theranostics; 2020; 10(3):968-997. PubMed ID: 31938046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review.
    Thakkar S; Sharma D; Kalia K; Tekade RK
    Acta Biomater; 2020 Jan; 101():43-68. PubMed ID: 31518706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy.
    Li W; Peng A; Wu H; Quan Y; Li Y; Lu L; Cui M
    Front Immunol; 2020; 11():601497. PubMed ID: 33408716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of Nanotherapy Response as a Function of the Tumor Microenvironment: Focus on Liver Metastasis.
    Frieboes HB; Raghavan S; Godin B
    Front Bioeng Biotechnol; 2020; 8():1011. PubMed ID: 32974325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer nanotherapy].
    Kathmann W
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S11-3. PubMed ID: 22438116
    [No Abstract]   [Full Text] [Related]  

  • 15. What potential does plasmonics-amplified synergistic immuno photothermal nanotherapy have for treatment of cancer?
    Vo-Dinh T; Inman BA
    Nanomedicine (Lond); 2018 Jan; 13(2):139-144. PubMed ID: 29231126
    [No Abstract]   [Full Text] [Related]  

  • 16. Imaging-assisted anticancer nanotherapy.
    Dasgupta A; Biancacci I; Kiessling F; Lammers T
    Theranostics; 2020; 10(3):956-967. PubMed ID: 31938045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancement and Applications of Nanotherapy for Cancer Immune Microenvironment.
    He JJ; Li QQ; Zhao C; Zhou J; Wu J; Zhang HB; Zhao YQ; Zhang HH; Lei TY; Zhao XY; You Z; Song QB; Xu B
    Curr Med Sci; 2023 Aug; 43(4):631-646. PubMed ID: 37558863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical prediction of nanoparticle delivery: from culture media to cell.
    Brown MR; Hondow N; Brydson R; Rees P; Brown AP; Summers HD
    Nanotechnology; 2015 Apr; 26(15):155101. PubMed ID: 25797791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
    Huo M; Wang L; Chen Y; Shi J
    Nat Commun; 2017 Aug; 8(1):357. PubMed ID: 28842577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the tumor microenvironment with nanoparticles.
    Miao L; Huang L
    Cancer Treat Res; 2015; 166():193-226. PubMed ID: 25895870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.